Cargando…
Toward Bifunctional Chelators for Thallium-201 for Use in Nuclear Medicine
[Image: see text] Auger electron therapy exploits the cytotoxicity of low-energy electrons emitted during radioactive decay that travel very short distances (typically <1 μm). (201)Tl, with a half-life of 73 h, emits ∼37 Auger and other secondary electrons per decay and can be tracked in vivo as...
Autores principales: | Rigby, Alex, Firth, George, Rivas, Charlotte, Pham, Truc, Kim, Jana, Phanopoulos, Andreas, Wharton, Luke, Ingham, Aidan, Li, Lily, Ma, Michelle T, Orvig, Chris, Blower, Philip J., Terry, Samantha Y.A., Abbate, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305974/ https://www.ncbi.nlm.nih.gov/pubmed/35801668 http://dx.doi.org/10.1021/acs.bioconjchem.2c00284 |
Ejemplares similares
-
Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals
por: Rigby, Alex, et al.
Publicado: (2021) -
In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201
por: Osytek, Katarzyna M., et al.
Publicado: (2021) -
New Bifunctional Chelators Incorporating Dibromomaleimide
Groups for Radiolabeling of Antibodies with Positron Emission Tomography
Imaging Radioisotopes
por: Farleigh, Matthew, et al.
Publicado: (2021) -
Tracing chameleon: thallium-201 SPECT/CT for pheochromocytoma
por: Wang, Yuh-Feng, et al.
Publicado: (2008) -
The role of thallium-201 and pentavalent dimercaptosuccinic acid for staging cartilaginous tumours
por: Choong, Peter FM, et al.
Publicado: (2004)